Stock listing

Frankfurt:S5YA Sigma Healthcare Ltd Aktie

German listing (Frankfurt) of Sigma Healthcare Ltd · home listing ASX:SIG

Follow Sigma Healthcare Ltd into a list and get an email when it puts out news.

Share price · FWB:S5YA

€1.72 EUR -0.01 (-0.6%)

Close on Nov 19, 2026

Past year +5.9% · daily closes, Nov 19, 2025 – Nov 6, 2026, adjusted for splits
Day range
€1.72 – €1.72 EURNov 19, 2026
Market cap
€19.78B EURAt the close on Nov 19, 2026 · price × 11.50B shares outstanding
52-week range
€1.52 – €1.84 EURLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
€54 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 19, 2026 – Nov 6, 2026
Sigma Healthcare Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
ASX:SIG · Home$2.89 AUD-0.01 (-0.3%)13,055,894$2.88$2.91$2.87$2.90Close on Nov 20, 2026
OTC:SIGGF$1.90 USD0.00 (0.0%)—$1.90$1.90$1.90$1.90Close on Nov 6, 2026
Frankfurt:S5YA€1.72 EUR-0.01 (-0.6%)—€1.72€1.72€1.72€1.73Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 6, 2026 · FWB:S5YA · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€1.6920.000.0%€1.693€1.693€1.6920
€1.692+0.007+0.4%€1.694€1.694€1.6870
€1.685-0.01-0.6%€1.681€1.69€1.680
€1.695+0.017+1.0%€1.695€1.695€1.6950
€1.678-0.007-0.4%€1.678€1.678€1.6780
€1.685+0.004+0.2%€1.685€1.685€1.685404
€1.681+0.006+0.4%€1.682€1.689€1.6770
€1.675-0.001-0.1%€1.675€1.675€1.67540
€1.676-0.022-1.3%€1.676€1.676€1.6760
€1.698+0.03+1.8%€1.69€1.706€1.6910
€1.668+0.002+0.1%€1.668€1.668€1.668626
€1.666-0.001-0.1%€1.666€1.666€1.6660
€1.667-0.046-2.7%€1.667€1.667€1.6670
€1.713+0.016+0.9%€1.713€1.713€1.7130
€1.697-0.011-0.6%€1.697€1.697€1.6970
€1.708+0.016+0.9%€1.708€1.708€1.7080
€1.692-0.017-1.0%€1.692€1.692€1.6920
€1.709+0.045+2.7%€1.709€1.709€1.7090
€1.664+0.011+0.7%€1.664€1.664€1.6640
€1.653+0.022+1.3%€1.653€1.653€1.6530
€1.631+0.057+3.6%€1.631€1.631€1.6310
€1.574-0.027-1.7%€1.574€1.574€1.5740
€1.601+0.02+1.3%€1.585€1.613€1.5780
€1.581-0.003-0.2%€1.581€1.581€1.5810
€1.584+0.019+1.2%€1.584€1.584€1.5840
€1.565+0.033+2.2%€1.565€1.565€1.565142
€1.532-0.029-1.9%€1.53€1.532€1.5270
€1.561+0.032+2.1%€1.561€1.561€1.5610
€1.529-0.007-0.5%€1.529€1.529€1.5290
€1.536-0.008-0.5%€1.541€1.542€1.5360
€1.544-0.022-1.4%€1.544€1.544€1.54490
€1.566+0.025+1.6%€1.566€1.566€1.5660
€1.541-0.002-0.1%€1.541€1.541€1.5410
€1.543+0.008+0.5%€1.543€1.543€1.5430
€1.535+0.02+1.3%€1.535€1.535€1.5350
€1.515-0.015-1.0%€1.515€1.515€1.515230
€1.53-0.037-2.4%€1.53€1.53€1.530
€1.567-0.025-1.6%€1.567€1.567€1.5670
€1.592+0.01+0.6%€1.592€1.592€1.5920
€1.582-0.005-0.3%€1.582€1.582€1.5820
€1.587-0.009-0.6%€1.587€1.587€1.58734
€1.596-0.023-1.4%€1.596€1.596€1.5960
€1.619-0.006-0.4%€1.619€1.619€1.6190
€1.625-0.001-0.1%€1.625€1.625€1.6250
€1.626-0.009-0.6%€1.626€1.626€1.6260
€1.635+0.007+0.4%€1.635€1.635€1.63532
€1.628-0.022-1.3%€1.628€1.628€1.6280
€1.65+0.011+0.7%€1.65€1.65€1.650
€1.639+0.003+0.2%€1.639€1.639€1.6390
€1.636+0.015+0.9%€1.636€1.636€1.6360
€1.621+0.04+2.5%€1.621€1.621€1.621246
€1.581-0.123-7.2%€1.581€1.581€1.5810
€1.704+0.01+0.6%€1.704€1.704€1.7040
€1.694-0.034-2.0%€1.694€1.694€1.6940
€1.728+0.015+0.9%€1.728€1.728€1.7280
€1.713+0.002+0.1%€1.713€1.713€1.71380
€1.711-0.003-0.2%€1.711€1.711€1.7110
€1.714-0.022-1.3%€1.714€1.714€1.7140
Ticker
Frankfurt:S5YA
Asset type
Stock
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

Change of Director's Interest Notice

Nov 1, 2026

Closed €1.68 (-0.4%) on Nov 2, 2026

Notification of cessation of securities - SIG

Oct 23, 2026

Closed €1.67 (+0.1%) on Oct 23, 2026

Sigma AGM Results of Meeting

Oct 21, 2026

Closed €1.67 (-2.7%) on Oct 21, 2026

AGM Trading Update - 21 October 2026

Oct 20, 2026

Closed €1.67 (-2.7%) on Oct 21, 2026

AGM Presentation to Shareholders

Oct 20, 2026

Closed €1.67 (-2.7%) on Oct 21, 2026

AGM Chairman & CEO Address to Shareholders

Oct 20, 2026

Closed €1.67 (-2.7%) on Oct 21, 2026

Sustainability Report 2026

Oct 9, 2026

Closed €1.63 (+3.6%) on Oct 9, 2026

Notice of ceasing to be a substantial holder

Sep 28, 2026

Closed €1.54 (-0.5%) on Sep 28, 2026

Notice of Annual General Meeting/Proxy Form

Sep 18, 2026

Closed €1.52 (-1.0%) on Sep 18, 2026

All Sigma Healthcare Ltd news

Sigma Healthcare Ltd on 6ix

News releases
30 in the last 12 months · 158 in all · newest Nov 10, 2026 · oldest 2016
Decks
47 decks · latest Oct 21, 2026

Where Sigma Healthcare Ltd is listed

ListingExchangeCountryCurrency
ASX:SIG · Home listingASXAustraliaAUD
LS Exchange:A2DYWBLS ExchangeGermanyEUR
OTC:SIGGFOTCUnited StatesUSD
Lang & Schwarz:A2DYWBLang & SchwarzGermanyEUR
Frankfurt:S5YA · This pageFrankfurtGermanyEUR
Tradegate:S5YATradegateGermanyEUR
Dusseldorf:S5YADusseldorfGermanyEUR
gettex:S5YAgettexGermanyEUR

Valuation

Statements: Year to Jan 31, 2026 · balance Apr 30, 2026 · price Nov 20, 2026

Enterprise value
$35.13B AUD
P/E
46.9×
EV/sales
3.2×
EV/EBITDA
32.4×
Price/book
6.7×
Gross margin
18.1%
Operating margin
9.2%
Net margin
6.6%
Debt to equity
0.4×
Beta
No index for this market yet

Forecasts

Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
3.15 AUD · Analysts' mean
EPS, year to Jun 2027
0.075 · 15 analysts
Revenue, year to Jun 2027
12.2B · 16 analysts

Team and board

Officers

OfficerRole
Mario VerrocchiCEO – Chemist Warehouse Group, Executive Director
Vikesh RamsunderManaging Director and CEO
Danielle Di PillaChief People Officer, Executive Director

Board

DirectorRole
Michael SammellsChairman, Non-Executive Director
Annette CareyNon-Executive Director
Chris RobertsNon-Executive Director
Damien GanceNon-Executive Director
Danielle Di PillaChief People Officer, Executive Director
Jack GanceNon-Executive Director
Mario VerrocchiCEO – Chemist Warehouse Group, Executive Director
Neville MitchellNon-Executive Director

Events

Next results
Feb 24, 2027 (expected)
QuarterResultsShare move
Quarter to Jul 31, 2026Aug 26, 2026−8.4%
Quarter to Jan 31, 2026Feb 25, 2026−2.0%
Q4 2025Mar 20, 2025−1.4%
Q4 2023Mar 23, 2023 · After close0.0%
Q2 2023Sep 26, 2022 · Before open−5.7%
Q4 2022Mar 28, 2022 · After close+1.9%
Q4 2021Mar 21, 2021+2.3%

Open Events

Decks

DeckKindSlidesDate
Shareholder Meeting (October 2026)Shareholder meeting15 slidesOct 21, 2026
FY2026 Earnings PresentationEarnings26 slidesAug 27, 2026
H1 2026 Earnings PresentationEarnings21 slidesFeb 26, 2026
Shareholder Meeting (October 2025)Shareholder meeting13 slidesOct 22, 2025
FY2025 Earnings PresentationEarnings27 slidesAug 27, 2025
Macquarie Sydney Conference 2025Conference15 slidesMay 6, 2025
H1 2025 Earnings PresentationEarnings24 slidesFeb 27, 2025
Shareholder Meeting (January 2025)Shareholder meeting39 slidesJan 29, 2025
H1 2025 Earnings PresentationEarnings28 slidesSep 25, 2024
Shareholder Meeting (May 2024)Shareholder meeting18 slidesMay 30, 2024
All 47 decks
DeckKindSlidesDate
FY2024 Earnings PresentationEarnings28 slidesMar 21, 2024
Investor Presentation (December 2023)Investor deck80 slidesDec 11, 2023
H1 2024 Earnings PresentationEarnings24 slidesSep 20, 2023
Shareholder Meeting (May 2023)Shareholder meeting16 slidesMay 17, 2023
FY2023 Earnings PresentationEarnings21 slidesMar 23, 2023
H1 2023 Earnings PresentationEarnings26 slidesSep 26, 2022
Shareholder Meeting (May 2022)Shareholder meeting17 slidesMay 12, 2022
FY2022 Earnings PresentationEarnings20 slidesMar 29, 2022
H1 FY2022 Earnings PresentationEarnings20 slidesSep 21, 2021
Investor Presentation (July 2021)Investor deck4 slidesJuly 2021
Shareholder Meeting (May 2021)Shareholder meeting21 slidesMay 12, 2021
FY2021 Earnings PresentationEarnings24 slidesMar 23, 2021
Citi Group Annual Investor Conference 2020Conference15 slidesOct 14, 2020
H1 FY2021 Earnings PresentationEarnings32 slidesSep 10, 2020
Shareholder Meeting (May 2020)Shareholder meeting25 slidesMay 13, 2020
FY2020 Earnings PresentationEarnings28 slidesMar 25, 2020
Investor Day (November 2019)Investor day62 slidesNov 26, 2019
H1 2020 Earnings PresentationEarnings24 slidesSep 5, 2019
Shareholder Meeting (May 2019)Shareholder meeting21 slidesMay 15, 2019
FY2019 Earnings PresentationEarnings30 slidesMar 21, 2019
Merger or Acquisition (December 2018)Merger or acquisition7 slidesDec 14, 2018
H1 2019 Earnings PresentationEarnings26 slidesSep 6, 2018
Shareholder Meeting (May 2018)Shareholder meeting21 slidesMay 16, 2018
FY2018 Earnings PresentationEarnings28 slidesMar 22, 2018
H1 FY2018 Earnings PresentationEarnings30 slidesSep 7, 2017
Sigma Pharmaceuticals — Non-Deal Roadshow (April 2017)Roadshow32 slidesApril 2017
Sigma Pharmaceuticals — FY2017 Earnings PresentationEarnings28 slidesMar 23, 2017
Non-Deal Roadshow (October 2016)Roadshow18 slidesOct 11, 2016
Sigma Pharmaceuticals — H1 2017 Earnings PresentationEarnings25 slidesSeptember 2016
Investor Presentation (March 2016)Investor deck19 slidesMar 30, 2016
Sigma Pharmaceuticals — FY2016 Earnings PresentationEarnings26 slidesMar 23, 2016
Sigma Pharmaceuticals — H1 2016 Earnings PresentationEarnings25 slidesSep 10, 2015
FY2015 Earnings PresentationEarnings27 slidesMar 19, 2015
H1 2015 Earnings PresentationEarnings26 slidesSep 11, 2014
Sigma Pharmaceuticals — FY2014 Earnings PresentationEarnings28 slidesMar 27, 2014
Sigma Pharmaceuticals — H1 2014 Earnings PresentationEarnings21 slidesSep 12, 2013
Sigma Pharmaceuticals — FY2012 Earnings PresentationEarnings25 slidesMar 22, 2012

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue10.8B4.89B3.32B3.66B3.45B3.40B3.24B3.98B4.09B4.37B
Cost of revenue8.88B4.56B3.13B3.44B3.25B3.19B3.06B3.70B3.81B4.08B
Gross profit1.96B334.1M189.8M224.1M199.4M210.6M187.8M273.2M284.4M289.5M
Selling, general and administrative461.8M384.0M88.6M82.6M93.0M94.4M68.0M63.6M65.6M59.5M
Operating income998.0M722.6M-71.9M-68.9M-110.2M-98.4M-101.0M-36.4M83.4M15.2M
Depreciation and amortization85.0M56.0M28.3M30.3M27.7M31.0M27.3M13.5M9.09M8.29M
EBITDA1.08B778.6M-43.6M-38.6M-82.5M-67.4M-73.7M-22.9M92.4M23.5M
Interest expense114.2M18.5M16.3M14.4M10.8M11.8M13.4M11.8M6.47M6.02M
Income before tax1.01B743.5M8.62M5.46M-8.31M28.6M-15.8M52.0M78.7M76.7M
Income tax296.4M218.0M3.31M2.44M-1.97M-16.5M-4.29M14.9M23.3M23.2M
Net income709.2M529.9M4.51M1.81M-7.24M43.5M-12.3M36.5M55.1M53.2M
Earnings per share, basic0.060.030.000.00-0.000.00-0.000.000.010.00

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents131.1M14.6M356.5M16.6M31.1M16.1M104.2M72.6M82.2M24.4M
Short-term investments-7.67M014.0K0
Receivables2.01B952.7M320.0M332.5M343.3M327.3M277.7M549.4M550.5M537.0M
Inventory1.25B383.4M221.1M324.9M321.6M349.1M315.5M343.3M350.5M322.0M
Current assets3.43B1.38B912.5M685.8M761.6M702.2M735.9M1.00B1.03B918.7M
Property, plant and equipment256.1M271.8M290.9M281.6M288.3M299.4M224.1M128.5M77.9M
Goodwill3.63B89.1M89.1M95.2M103.0M103.0M103.0M93.1M93.1M80.8M
Total assets8.91B1.83B1.40B1.20B1.28B1.22B1.23B1.38B1.30B1.12B
Accounts payable1.30B726.4M303.4M406.0M352.3M365.5M360.0M492.8M526.5M475.3M
Current liabilities2.05B865.0M371.3M477.4M457.6M523.7M576.0M663.3M781.0M574.6M
Long-term debt752.2M855.3M080.0M165.0M0115.2M200.8M788.0K1.02M
Total debt2.02B132.1M136.6M227.0M323.4M215.2M300.2M315.8M195.8M33.2M
Total liabilities3.92B991.3M531.5M723.8M786.7M705.0M752.7M869.6M789.5M580.3M
Shareholders' equity5.00B837.9M870.8M475.9M487.2M513.7M476.0M513.3M513.1M536.8M
Shares outstanding11.5B15.7B10.6B10.3B10.2B10.3B10.1B10.1B10.3B10.7B

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations574.6M598.8M42.0M33.4M27.7M12.5M200.6M8.47M71.2M145.8M
Capital spending-56.7M-7.91M-4.72M-29.4M-14.2M-77.0M-57.1M-108.2M-62.3M-25.2M
Free cash flow517.9M-323.5M37.2M3.96M13.5M-64.6M143.5M-99.7M8.89M120.6M
Cash from investing62.6M-1.60M5.73M-28.6M-16.6M98.8M-68.4M-101.6M-94.5M-30.5M
Cash from financing-645.2M-24.7M295.8M-116.9M128.9M-265.7M-100.6M83.5M113.3M-67.5M
Dividends paid-378.8M-17.1M-9.98M-15.9M-19.9M-1.59M-30.7M-41.0M-55.2M-55.7M
Share buybacks2.68M-9.50M879.0K195.0K-50.0K-50.0K-4.14M-30.7M-24.6M
Change in cash-7.65M-341.9M343.5M-2.80M66.0M-154.5M31.6M-9.64M90.0M47.9M

Open Financials

Filings

FilingDateTypeFiled with
Change in substantial holdingNov 10, 2026Ownership change noticeASX
Change of Director's Interest NoticeNov 1, 2026Ownership change noticeASX
Notification of cessation of securities - SIGOct 23, 2026FinancingASX
Sigma AGM Results of MeetingOct 21, 2026Meeting outcomeASX
AGM Trading Update - 21 October 2026Oct 20, 2026ResultsASX
AGM Trading Update - 21 October 2026Oct 20, 2026Operations updateASX
AGM Presentation to ShareholdersOct 20, 2026Other filingsASX
AGM Presentation to ShareholdersOct 20, 2026Other filingsASX
AGM Chairman & CEO Address to ShareholdersOct 20, 2026Meeting outcomeASX
AGM Chairman & CEO Address to ShareholdersOct 20, 2026Meeting outcomeASX
All 157 filings
FilingDateTypeFiled with
Sustainability Report 2026Oct 9, 2026ESG reportASX
Notice of ceasing to be a substantial holderSep 28, 2026Ownership change noticeASX
Change of Director's Interest NoticeSep 20, 2026Ownership change noticeASX
Notice of Annual General Meeting/Proxy FormSep 18, 2026Meeting noticeASX
Change of Director's Interest NoticeSep 16, 2026Ownership change noticeASX
Appendix 3YSep 6, 2026Other filingsASX
Sigma Corporate Governance Statement 2026Aug 26, 2026Other filingsASX
Sigma Full Year Results PresentationAug 26, 2026ResultsASX
Sigma Full Year Results ASX ReleaseAug 26, 2026ResultsASX
2026 Appendix 4E and Annual ReportAug 26, 2026Annual reportASX
Dividend/Distribution - SIGAug 26, 2026DividendASX
Appendix 4GAug 26, 2026Other filingsASX
Sigma 2026 AGMAug 24, 2026Meeting noticeASX
Sigma FY26 Full Year Results InformationAug 13, 2026ResultsASX
Withdrawal from Boots sale processJun 14, 2026Acquisition or disposalASX
Macquarie Australia Conference 2026 - UpdateMay 4, 2026Operations updateASX
Sigma Half Year Results ASX ReleaseFeb 25, 2026ResultsASX
Half Year AccountsFeb 25, 2026Interim reportASX
Sigma Half Year Results PresentationFeb 25, 2026Interim reportASX
AGM Chairman & CEO Address to ShareholdersOct 21, 2025Meeting outcomeASX
AGM Presentation to ShareholdersOct 21, 2025Other filingsASX
Appendix 4E & Full Year Financial ReportAug 26, 2025ResultsASX
Sigma Full Year FY25 ASX ReleaseAug 26, 2025ResultsASX
Sigma Full Year FY25 Results PresentationAug 26, 2025Other filingsASX
Trading UpdateMay 5, 2025Other filingsASX
Sigma Full Year 2024/25 ASX ReleaseMar 19, 2025ResultsASX
Sigma Appendix 4E & Full Year Financial ReportMar 19, 2025ResultsASX
S&P DJI Announces March 2025 Quarterly RebalanceMar 7, 2025Other filingsASX
Sigma FY25 Trading UpdateFeb 6, 2025Other filingsASX
Merger with Chemist Warehouse - Scheme Meeting ResultsJan 29, 2025Acquisition or disposalASX
Merger with Chemist Warehouse - General Meeting ResultsJan 29, 2025Meeting outcomeASX
Trading HaltJan 28, 2025Trading halt or suspensionASX
CW - Trading Update 1H FY25 Record Sales & Margin ExpansionJan 28, 2025Operations updateASX
Sigma - Draft ProspectusDec 18, 2024Offer documentASX
Sigma Notice of MeetingDec 18, 2024Meeting noticeASX
Chemist Warehouse Scheme Meeting and Scheme BookletDec 13, 2024Offer documentASX
Sigma welcomes the ACCC's decisionNov 6, 2024Other filingsASX
Half Year Results PresentationSep 24, 2024Interim reportASX
Half Yearly Reports & AccountsSep 24, 2024Interim reportASX
Half Year ResultsSep 24, 2024ResultsASX
Sigma Acknowledges ACCC AnnouncementJun 13, 2024Acquisition or disposalASX
Boral Limited to be removed from the S&P/ASX 200 IndexMay 2, 2024Other filingsASX
Sigma Full Year 2023/24 Results PresentationMar 20, 2024Other filingsASX
Sigma Full Year 2023/24 ASX ReleaseMar 20, 2024ResultsASX
Successful Completion of Retail Entitlement OfferJan 23, 2024FinancingASX
Retail Offer Booklet and Letters to Retail ShareholdersDec 17, 2023Offer documentASX
Reinstatement to Official QuotationDec 12, 2023Trading halt or suspensionASX
Institutional Completion AnnouncementDec 12, 2023FinancingASX
Investor Presentation Merger & Equity RaisingDec 10, 2023Acquisition or disposalASX
Transformational Merger & Equity RaisingDec 10, 2023Acquisition or disposalASX
Voluntary SuspensionDec 7, 2023Trading halt or suspensionASX
Pause in TradingDec 6, 2023Trading halt or suspensionASX
Dividend/Distribution - SIGSep 20, 2023DividendASX
Half Yearly Report and AccountsSep 20, 2023Interim reportASX
Sigma Awarded Chemist Warehouse Supply ContractJun 5, 2023Other filingsASX
Sigma Full Year 2022/23 Results PresentationMar 22, 2023Other filingsASX
Sigma Full Year 2022/23 ASX ReleaseMar 22, 2023Other filingsASX
Business Update - Supplementary AnnouncementMar 10, 2023Operations updateASX
Business UpdateMar 9, 2023Operations updateASX
Sigma secures refinancing of Debt facilityNov 28, 2022Other filingsASX
Chairman & CEOs Address to ShareholdersMay 12, 2022Other filingsASX
Sigma Full Year 2021/22 Results PresentationMar 28, 2022Other filingsASX
Sigma Full Year 2021/2022 ASX ReleaseMar 28, 2022Other filingsASX
Profit GuidanceMar 1, 2022GuidanceASX
SIG: Withdrawal of API merger proposalNov 4, 2021Acquisition or disposalASX
SIG: Proposal to merge with APISep 26, 2021Other filingsASX
Unsolicited, Non-binding, Conditional Proposal from SIGSep 26, 2021Other filingsASX
CEO AppointmentSep 23, 2021Other filingsASX
ASX Release Half Year ResultsSep 20, 2021Interim reportASX
CEO resignation announcementApr 25, 2021Other filingsASX
Sigma Full Year 2020/2021 Results PresentationMar 22, 2021Other filingsASX
Sigma Full Year 2020/2021 ASX ReleaseMar 22, 2021Other filingsASX
Appendix 4E and Full Year Financial ReportMar 22, 2021ResultsASX
Trading updateFeb 7, 2021Other filingsASX
Half Year 2020/21 Results PresentationSep 9, 2020Other filingsASX
Half Year 2020/21 ASX ReleaseSep 9, 2020Other filingsASX
Appendix 4D- Half Year Financial ReportSep 9, 2020Interim reportASX
Sigma sells two Distribution Centres for $172mAug 9, 2020Other filingsASX
Industry funding agreementJun 16, 2020Other filingsASX
Incoming Chairmans AddressMay 13, 2020Other filingsASX
CEOs Address to ShareholdersMay 13, 2020Other filingsASX
Chairmans Address to ShareholdersMay 13, 2020Other filingsASX
Sigma 2019/2020 Full Year Results PresentationMar 24, 2020ResultsASX
Sigma 2019/2020 Full Year ASX ReleaseMar 24, 2020Other filingsASX
Market Update - Securing our longer-term futureMar 17, 2020Other filingsASX
Market updateFeb 6, 2020Other filingsASX
Market UpdateDec 12, 2019Other filingsASX
Sigma Investor Day PresentationNov 25, 2019Other filingsASX
Market Update - new MC/CW supply agreementNov 24, 2019Other filingsASX
Citi Group Investor ConferenceOct 15, 2019Other filingsASX
S&P DJI Announces September 2019 Quarterly RebalanceSep 5, 2019Other filingsASX
Sigma 2019/20 Half Year Results PresentationSep 4, 2019Interim reportASX
Sigma 2019/20 Half Year ASX ReleaseSep 4, 2019Other filingsASX
Appendix 4D - Half year financial reportSep 4, 2019Interim reportASX
Sigma 2018/2019 Full Year Results PresentationMar 20, 2019ResultsASX
Sigma 2018/2019 Full Year ASX ReleaseMar 20, 2019Other filingsASX
Update on API proposalMar 12, 2019Other filingsASX
Debt Refinancing AgreementDec 16, 2018Other filingsASX
Rescheduled Investor BriefingDec 14, 2018Other filingsASX
API: API announces merger proposal with SigmaDec 13, 2018Acquisition or disposalASX
Company UpdateDec 13, 2018Other filingsASX
Sigma 2018/19 Half Year Results PresentationSep 5, 2018Interim reportASX
Sigma 2018/19 Half Year ASX ReleaseSep 5, 2018Other filingsASX
CEO Address to ShareholdersMay 16, 2018Other filingsASX
Changes relating to buy-back - Appendix 3DNov 6, 2017Treasury share statusASX
Settlement reached with My Chemist / Chemist WarehouseOct 16, 2017Other filingsASX
2018 Half Year Media / ASX ReleaseSep 6, 2017Other filingsASX
Sigma acquires MPSSep 6, 2017Acquisition or disposalASX
Trading Update - My Chemist/ Chemist Warehouse GroupJul 25, 2017Other filingsASX
Trading Update - CSO Deed compensation agreedJun 28, 2017Other filingsASX
Trading Update - CHS signs Department of Defence agreementJun 16, 2017Other filingsASX
Trading Update - My Chemist/Chemist Warehouse GroupMay 29, 2017Other filingsASX
Sigma 2016/17 Full Year ASX ReleaseMar 22, 2017Other filingsASX
Announcement - Sigma partnership with Fred IT GroupNov 23, 2016Other filingsASX
Sigma Pharmaceuticals Asian Roadshow 11 - 13 Oct 2016Oct 10, 2016Other filingsASX
2017 Half Year Media/ASX ReleaseSep 7, 2016Other filingsASX
Market update - final adjustment for historical class actionMay 13, 2016Other filingsASX
Sigma 2015/16 Half Year ReportMar 30, 2016Interim reportASX
Appointment of Managing Director and CEOMar 30, 2016Management or board changeASX
Notification of ApproachMar 30, 2016Other filingsASX
Board ResignationsMar 30, 2016Other filingsASX
Resignation of Managing Director and CEOMar 30, 2016Management or board changeASX
Chairman`s Address to ShareholdersMar 30, 2016Other filingsASX
SIP: Update on Proposal from AspenMar 30, 2016Other filingsASX
Sigma Pharmaceuticals Limited - AGMMar 30, 2016Other filingsASX
Sigma 2012 Half Year ReportMar 30, 2016Interim reportASX
Investor Update PresentationMar 30, 2016Other filingsASX
Dividend DetailsMar 30, 2016DividendASX
SIP: Court Approval of Settlement of Class ActionMar 30, 2016Legal or regulatory actionASX
Sigma 2013/14 Full Year ReportMar 30, 2016Other filingsASX
SIP: Market UpdateMar 30, 2016Other filingsASX
Preliminary Final ReportMar 22, 2016ResultsASX
Acquisitions exceed expectationsFeb 11, 2016Acquisition or disposalASX
Sigma 2014/15 Full Year ReportFeb 10, 2016Other filingsASX
Sigma 2014/15 Half Year ReportFeb 10, 2016Interim reportASX
Sigma 2013/14 Half Year ReportFeb 10, 2016Interim reportASX
Market Update - Announces MOU with Pharmacy AllianceFeb 10, 2016Other filingsASX
Sigma Settles Class ActionFeb 10, 2016Other filingsASX
Announcement of buy-back - Appendix 3CFeb 10, 2016Treasury share statusASX
Sigma 2011 Half Year ReportFeb 10, 2016Interim reportASX
Sigma Appointed as Preferred WholesalerFeb 10, 2016Other filingsASX
Sigma 2010 Half Year ReportFeb 10, 2016Interim reportASX
Sigma Proposed Sale of Pharmaceuticals DivisionFeb 10, 2016Other filingsASX
Response to media speculationFeb 10, 2016Other filingsASX
Financial UpdateFeb 10, 2016Other filingsASX
Update on Proposal from Aspen GroupFeb 10, 2016Other filingsASX
Sigma grants Aspen Pharmacare access to due diligenceFeb 10, 2016Other filingsASX

Open Filings

Cap table

Built by 6ix from Sigma Healthcare Ltd’s releases

Common shares
11,502,746,000
Fully diluted
11,502,746,000

Fully diluted

LineShares
Common shares11,502,746,000

Share count over time

CountShares
Nov 22, 202611,502,746,000

Open Cap table

Shareholders

Funds

HolderSharesValueChangeAs of
Vanguard Total International Stock Index Fund75.1MUS$155M+480KJul 31, 2026
Vanguard Developed Markets Index Fund49.8MUS$94.9M+479KJun 30, 2026
iShares Core MSCI EAFE ETF39.1MUS$80.5M+2.36MJul 31, 2026
Fidelity International Index Fund19.5MUS$41.3M+587KMay 31, 2026
iShares MSCI EAFE ETF18MUS$37.2M−14,448Jul 31, 2026
JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF17.9MUS$36.9M+1.8MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund12.1MUS$25M+331KJul 31, 2026
Schwab International Equity ETF11.2MUS$23.7M+2.16MMay 31, 2026
Fidelity Series Global ex U.S. Index Fund10.3MUS$21.3M+433KJul 31, 2026
Nuveen International Equity Index Fund8.59MUS$17.7M+535KJul 31, 2026
Show 50 holders
HolderSharesValueChangeAs of
iShares MSCI EAFE Growth ETF7.98MUS$16.5M+208KJul 31, 2026
iShares Core MSCI Total International Stock ETF7.22MUS$14.9MNo changeJul 31, 2026
International Core Equity 2 Portfolio7.07MUS$14.6M−114KJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF6.52MUS$12.4M−6,592Jun 30, 2026
iShares ESG Aware MSCI EAFE ETF6.03MUS$12.7M+370KMay 31, 2026
iShares Core MSCI International Developed Markets ETF5.8MUS$12M+565KJul 31, 2026
Vanguard Pacific Stock Index Fund5.5MUS$11.3M−138KJul 31, 2026
iShares MSCI Australia ETF5.27MUS$11.1M+270KMay 31, 2026
iShares MSCI Pacific ex Japan ETF4.81MUS$10.1M+40,982May 31, 2026
iShares MSCI EAFE Min Vol Factor ETF4.51MUS$9.31M−82,620Jul 31, 2026
Vanguard Total World Stock Index Fund4.15MUS$8.56M+106KJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account3.74MUS$7.13M+8,155Jun 30, 2026
Schwab International Index Fund3.51MUS$7.23M+138KJul 31, 2026
iShares MSCI EAFE International Index Fund3.29MUS$6.27M+49,802Jun 30, 2026
Fidelity Total International Index Fund3.02MUS$6.22M+204KJul 31, 2026
iShares Global Healthcare ETF2.88MUS$5.49M+159KJun 30, 2026
Fidelity Global ex U.S. Index Fund2.72MUS$5.61M+73,977Jul 31, 2026
Fidelity SAI International Index Fund2.17MUS$4.48M+71,091Jul 31, 2026
Xtrackers MSCI EAFE Hedged Equity ETF1.94MUS$4.09M−30,406May 29, 2026
JPMorgan BetaBuilders International Equity ETF1.81MUS$3.73M+138KJul 31, 2026
Fidelity ZERO International Index Fund1.76MUS$3.63M+157KJul 31, 2026
iShares MSCI ACWI ETF1.75MUS$3.62M−3,932Jul 31, 2026
Dimensional International Core Equity Market ETF1.72MUS$3.55M+221KJul 31, 2026
iShares MSCI ACWI ex U.S. ETF1.65MUS$3.4M+51,788Jul 31, 2026
International Equity Index Fund1.57MUS$2.99M+55,105Jun 30, 2026
Dimensional International Core Equity 2 ETF1.52MUS$3.15MNo changeJul 31, 2026
iShares Core MSCI Pacific ETF1.48MUS$3.05M+87,622Jul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio1.46MUS$2.79MNo changeJun 30, 2026
Fidelity SAI International Momentum Index Fund1.43MUS$2.94M+51,532Jul 31, 2026
International Sustainability Core 1 Portfolio1.39MUS$2.87M−439KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF1.25MUS$2.57MNo changeJul 31, 2026
Nuveen ESG International Developed Markets Equity ETF1.13MUS$2.32M+9,644Jul 31, 2026
State Street International Developed Equity Index Portfolio1.08MUS$2.05M+123KJun 30, 2026
Vanguard ESG International Stock ETF1.01MUS$2.14M+169KMay 31, 2026
Six Circles Managed Equity Portfolio International Unconstrained Fund976KUS$1.86MNo changeJun 30, 2026
International Vector Equity Portfolio890KUS$1.84M−20,395Jul 31, 2026
Empower International Index Fund833KUS$1.59MNo changeJun 30, 2026
JNL International Index Fund825KUS$1.57MNo changeJun 30, 2026
College Retirement Equities Fund - Responsible Balanced Account812KUS$1.55M+87,270Jun 30, 2026
WisdomTree Global ex-U.S. Quality Growth Fund807KUS$1.54M+10,167Jun 30, 2026

This page holds 50 of 175 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Annette CAREY
Director
Buy20,000AUD 2.75AUD 55,000Oct 28, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Annette CareyNon-Executive Director · Since at least Nov 5, 2026
Chris RobertsNon-Executive Director · Since at least Nov 5, 2026
Damien GanceNon-Executive Director · Since at least Nov 5, 2026
Danielle Di PillaChief People Officer, Executive Director · Since at least Nov 5, 2026
Jack GanceNon-Executive Director · Since at least Nov 5, 2026
Mario VerrocchiCEO – Chemist Warehouse Group, Executive Director · Since at least Nov 5, 2026
Michael SammellsChairman, Non-Executive Director · Since at least Oct 20, 2026
Neville MitchellNon-Executive Director · Since at least Nov 5, 2026
Vikesh RamsunderManaging Director and CEO · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Sigma Healthcare Ltd.